Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia

New England Journal of Medicine - Tập 353 Số 20 - Trang 2121-2134 - 2005
Jean‐Pierre Després1, Alain Golay2, Lars Sjöström3
1Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, Ste.-Foy, Que., Canada
2Service of Therapeutic Education for Chronic Diseases, University Hospital Geneva, Geneva
3Department of Body Composition and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0092-8674(03)01081-X

10.1038/nrd1495

10.1172/JCI17725

10.1172/JCI19376

10.1126/science.1470919

10.1073/pnas.061029898

10.1124/pr.54.2.161

10.1038/35071088

10.1038/sj.bjp.0704767

10.1016/S0140-6736(05)66348-9

10.1161/01.ATV.0000099786.99623.EF

Jbilo O, 2005, FASEB J, 19, 1567, 10.1096/fj.04-3177fje

10.1124/mol.63.4.908

10.1016/S0140-6736(05)66374-X

10.1001/jama.285.19.2486

10.1111/j.1600-0447.1983.tb09716.x

10.1161/hc4401.098490

10.1161/01.CIR.0000111245.75752.C6

10.1136/bmj.322.7299.1379

Ross R, 2000, Ann Intern Med, 133, 92, 10.7326/0003-4819-133-2-200007180-00008

10.1161/01.ATV.10.4.497

10.2337/diacare.19.6.629

10.1001/jama.282.24.2340

10.1016/S0021-9150(99)00216-6

10.1016/S0002-9149(01)01448-5

10.2337/diacare.28.9.2289

10.1161/01.ATV.21.6.961

10.1161/01.CIR.0000132467.45278.59

10.1161/hc0502.103331

10.1161/01.ATV.21.6.968

10.1038/31701

10.1001/jama.286.1.64

10.2337/diabetes.46.10.1594

Kanai H, 1996, Hypertension, 27, 125, 10.1161/01.HYP.27.1.125

10.1001/jama.291.14.1730

10.1016/S0140-6736(03)12255-6

10.1210/jc.2004-1711